160 related articles for article (PubMed ID: 2147864)
1. Down's syndrome and acute leukemia in children: an analysis of phenotype by use of monoclonal antibodies and electron microscopic platelet peroxidase reaction.
Kojima S; Matsuyama T; Sato T; Horibe K; Konishi S; Tsuchida M; Hayashi Y; Kigasawa H; Akiyama Y; Okamura J
Blood; 1990 Dec; 76(11):2348-53. PubMed ID: 2147864
[TBL] [Abstract][Full Text] [Related]
2. Leukemic blasts with markers of four cell lineages in Down's syndrome ("megakaryoblastic leukemia").
Slørdahl SH; Smeland EB; Holte H; Grønn M; Lie SO; Seip M
Med Pediatr Oncol; 1993; 21(4):254-8. PubMed ID: 8469219
[TBL] [Abstract][Full Text] [Related]
3. Myelodysplasia and acute megakaryoblastic leukemia in Down's syndrome.
Zipursky A; Thorner P; De Harven E; Christensen H; Doyle J
Leuk Res; 1994 Mar; 18(3):163-71. PubMed ID: 8139285
[TBL] [Abstract][Full Text] [Related]
4. Ultrastructural studies of the megakaryoblastic leukemias of Down syndrome.
Zipursky A; Christensen H; De Harven E
Leuk Lymphoma; 1995 Jul; 18(3-4):341-7. PubMed ID: 8535203
[TBL] [Abstract][Full Text] [Related]
5. Acute megakaryoblastic leukemia with translocation t(1;22)(p13;q13) in a 10-week-old infant.
Washio S; Ido M; Azuma E; Fukui M; Shibata T; Zhang SL; Komada Y; Ito M; Koike T; Kaneko Y
Am J Hematol; 1992 Jan; 39(1):56-60. PubMed ID: 1311146
[TBL] [Abstract][Full Text] [Related]
6. Ultrastructural and ultracytochemical differences between megakaryoblastic leukemia in children and adults. Analysis of 49 patients.
Eguchi M; Ozawa T; Sakakibara H; Sugita K; Iwama Y; Furukawa T
Cancer; 1992 Jul; 70(2):451-8. PubMed ID: 1319816
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric analysis of peroxidase negative acute leukemias by monoclonal antibodies--II. Acute megakaryoblastic and acute pro-megakaryocytic leukemias.
Imamura N; Kajihara H; Kuramoto A
Leuk Res; 1988; 12(4):279-89. PubMed ID: 3163741
[TBL] [Abstract][Full Text] [Related]
8. The c-sis gene expression in cells from a patient with acute megakaryoblastic leukemia and Down's syndrome.
Sunami S; Fuse A; Simizu B; Eguchi M; Hayashi Y; Sugita K; Nakazawa S; Okimoto Y; Sato T; Nakajima H
Blood; 1987 Aug; 70(2):368-71. PubMed ID: 2955817
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts.
Langebrake C; Creutzig U; Reinhardt D
Klin Padiatr; 2005; 217(3):126-34. PubMed ID: 15858703
[TBL] [Abstract][Full Text] [Related]
10. Significance of common acute lymphoblastic leukemia antigen (cALLA) positive cells in bone marrow of children off therapy in complete remission.
Self SE; Morgan S; Grush O; La Via MF
Hematol Oncol; 1990; 8(2):91-5. PubMed ID: 2140561
[TBL] [Abstract][Full Text] [Related]
11. An effective chemotherapeutic regimen for acute myeloid leukemia and myelodysplastic syndrome in children with Down's syndrome.
Kojima S; Sako M; Kato K; Hosoi G; Sato T; Ohara A; Koike K; Okimoto Y; Nishimura S; Akiyama Y; Yoshikawa T; Ishii E; Okamura J; Yazaki M; Hayashi Y; Eguchi M; Tsukimoto I; Ueda K
Leukemia; 2000 May; 14(5):786-91. PubMed ID: 10803507
[TBL] [Abstract][Full Text] [Related]
12. Mixed phenotype of blasts in acute megakaryocytic leukaemia and transient abnormal myelopoiesis in Down's syndrome.
Yumura-Yagi K; Hara J; Kurahashi H; Nishiura T; Kaneyama Y; Osugi Y; Sakata N; Inoue M; Tawa A; Okada S
Br J Haematol; 1992 Aug; 81(4):520-5. PubMed ID: 1390239
[TBL] [Abstract][Full Text] [Related]
13. Megakaryoblastic leukemia and Down's syndrome: a review.
Zipursky A; Peeters M; Poon A
Pediatr Hematol Oncol; 1987; 4(3):211-30. PubMed ID: 2978961
[TBL] [Abstract][Full Text] [Related]
14. Myelodysplasia and acute myelogenous leukemia in Down's syndrome. A report of 40 children of the AML-BFM Study Group.
Creutzig U; Ritter J; Vormoor J; Ludwig WD; Niemeyer C; Reinisch I; Stollmann-Gibbels B; Zimmermann M; Harbott J
Leukemia; 1996 Nov; 10(11):1677-86. PubMed ID: 8892666
[TBL] [Abstract][Full Text] [Related]
15. The pathomorphological diagnosis of acute leukaemias: cytology, cytochemistry and immunocytology.
Kelényi G; Kalász V; Matolcsy A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(1):31-6. PubMed ID: 2472325
[TBL] [Abstract][Full Text] [Related]
16. A case of acute megakaryocytic leukemia with hematogones.
Richard G; Brody J; Sun T
Leukemia; 1993 Nov; 7(11):1900-3. PubMed ID: 8231260
[TBL] [Abstract][Full Text] [Related]
17. [Megakaryoblastic leukemia and transient abnormal myelopoiesis with Down's syndrome].
Suda J; Eguchi M
Rinsho Ketsueki; 1988 Aug; 29(8):1200-6. PubMed ID: 2974493
[No Abstract] [Full Text] [Related]
18. Expression of CD15 as predictor of relapse in children with acute lymphoblastic leukemia of the pre-B type.
Lenkei R; Björk O; Ost A; Biberfeld P
Leuk Res; 1991; 15(4):189-94. PubMed ID: 1674292
[TBL] [Abstract][Full Text] [Related]
19. Ultrastructural and ultracytochemical differences between transient myeloproliferative disorder and megakaryoblastic leukaemia in Down's syndrome.
Eguchi M; Sakaibara H; Suda J; Ozawa T; Hayashi Y; Sato T; Kojima S; Furukawa T
Br J Haematol; 1989 Nov; 73(3):315-22. PubMed ID: 2532535
[TBL] [Abstract][Full Text] [Related]
20. Acute megakaryoblastic leukemia.
Gassmann W; Löffler H
Leuk Lymphoma; 1995; 18 Suppl 1():69-73. PubMed ID: 7496359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]